Translational Neural Devices (R61/R33 - Clinical Trial Optional)
ID: 352612Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Feb 23, 2024 12:00 AM
  4. 4
    Due Jan 28, 2027 12:00 AM
Description

The National Institutes of Health is offering a grant opportunity titled "Translational Neural Devices (R61/R33 - Clinical Trial Optional)". This grant aims to support the development of therapeutic and diagnostic devices for disorders affecting the nervous or neuromuscular systems. The funding will be used to facilitate translational activities and small clinical studies, including the implementation of clinical prototype devices, safety and efficacy testing, design verification and validation activities, and obtaining necessary approvals for clinical studies. The grant is open to various eligible applicants, including academic institutions, government agencies, and non-domestic entities. The deadline for application submission is January 28, 2027. For more information and to apply, visit the following link: Translational Neural Devices Grant.

Point(s) of Contact
Files
Title
Posted
Similar Opportunities
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)". This grant aims to support the development of the next generation of brain stimulation devices for treating mental health disorders. The funding opportunity encourages applications that will either develop novel brain stimulation devices or enhance the effectiveness of currently FDA-approved or cleared devices through hardware/software improvements. The focus is on developing new stimulation techniques with increased spatiotemporal precision, multi-focal and closed-loop approaches. The grant does not cover incremental changes to existing devices. Other eligible applicants include various institutions and organizations. The deadline for application submission is January 7, 2025. For more information, visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-039.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-039.html).
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)". This grant aims to support the development of therapeutic and diagnostic devices for disorders affecting the nervous or neuromuscular systems. The program will fund translational activities and small clinical studies, including the implementation of clinical prototype devices, safety and efficacy testing, design verification and validation activities, and obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study. The grant is a cooperative agreement program and will involve NIH program staff in negotiating the final project plan and monitoring research progress. Eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The deadline for applications is January 28, 2027. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-016.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-016.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)". This grant aims to support the development of the next generation of brain stimulation devices for treating mental health disorders. The funding opportunity encourages applications that will either develop novel brain stimulation devices or enhance the effectiveness of currently FDA-approved or cleared devices through hardware/software improvements. The focus is on developing new stimulation techniques with increased spatiotemporal precision, multi-focal and closed-loop approaches. Incremental changes to existing devices are not within the scope of this announcement. Applications should be submitted by multi-disciplinary teams with expertise in systems neuroscience, engineering, clinical, and regulatory affairs. For more information, visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-038.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-038.html).
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)". This grant aims to support the development and testing of innovative technologies and approaches for recording and modulation of cells and networks in the central nervous system (CNS). The goal is to gain a transformative understanding of dynamic signaling in the CNS at various spatial and temporal scales. The proposed technologies should be compatible with experiments in behaving animals and capable of reducing barriers to conducting neurobiological experiments. The grant encourages the integration of multiple approaches and expertise from biological, chemical, physical sciences, engineering, computational modeling, and statistical analysis. The deadline for application submission is January 20, 2026. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-004.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-004.html).
BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)". This grant aims to support activities that facilitate the translation of novel recording and modulation technologies for the treatment and diagnosis of central nervous system (CNS) diseases and disorders. The technologies may utilize various signal modalities such as electrical, optical, magnetic, or acoustic, either individually or in combination. The grant encourages diverse team-based applications that integrate different areas of expertise. The deadline for application submission is January 28, 2027. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-031.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-031.html).